HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rahasson R Ager Selected Research

hydrocinnamate- cyclo(ornithyl- prolyl- cyclohexylalanyl- tryptophyl- arginyl)

4/2010Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's disease.
7/2009Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rahasson R Ager Research Topics

Disease

4Inflammation (Inflammations)
10/2019 - 07/2009
4Alzheimer Disease (Alzheimer's Disease)
01/2018 - 04/2010
2Neuroinflammatory Diseases
04/2010 - 07/2009
1Disease Progression
07/2015
1Cognitive Dysfunction
01/2015
1Proteostasis Deficiencies
07/2014
1Infections
06/2010
1Neurodegenerative Diseases (Neurodegenerative Disease)
04/2010
1Dementia (Dementias)
04/2010
1Amyloid Plaque
07/2009

Drug/Important Bio-Agent (IBA)

3Complement System Proteins (Complement)IBA
06/2010 - 07/2009
2hydrocinnamate- cyclo(ornithyl- prolyl- cyclohexylalanyl- tryptophyl- arginyl)IBA
04/2010 - 07/2009
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
01/2018
1lipoxin A4IBA
01/2015
1Amyloid (Amyloid Fibrils)IBA
07/2014
1Amyloid beta-PeptidesIBA
04/2010
1Biological ProductsIBA
09/2009
1Anaphylatoxin C5a ReceptorIBA
07/2009

Therapy/Procedure

1Therapeutics
10/2019
1Investigational Therapies (Experimental Therapy)
07/2015